Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B.
Abstract
Drug hypersensitivity syndrome induced by meglumine antimoniate.
Abstract
Early curative applications of the aminoglycoside WR279396 on an experimental Leishmania major-loaded cutaneous site do not impair the acquisition of immunity.
Abstract
LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014.
Abstract
Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.
Abstract
Optimization of topical therapy for Leishmania major localized cutaneous leishmaniasis using a reliable C57BL/6 Model.
Abstract
Pseudomonas aeruginosa otochondritis complicating localized cutaneous leishmaniasis: prevention of mutilation by early antibiotic therapy.
Abstract
AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient.
Abstract
Clinical aspects and management of cutaneous leishmaniasis in rheumatoid patients treated with TNF-α antagonists.
Abstract
Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.
Abstract